Health Catalyst, Inc. HCAT
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -12.68% | -10.90% | -6.19% | -0.04% | 6.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -12.68% | -10.90% | -6.19% | -0.04% | 6.35% |
| Cost of Revenue | -16.99% | -15.87% | -21.13% | -11.23% | 6.04% |
| Gross Profit | -7.94% | -5.44% | 12.98% | 13.72% | 6.69% |
| SG&A Expenses | -39.09% | -19.47% | -13.17% | 2.78% | 28.54% |
| Depreciation & Amortization | -13.44% | -1.66% | 25.48% | 26.35% | 19.02% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.88% | -16.66% | -16.05% | -5.17% | 10.85% |
| Operating Income | 77.61% | 50.32% | 75.67% | 37.27% | -39.09% |
| Income Before Tax | 1.65% | -370.15% | -352.14% | -45.96% | -204.16% |
| Income Tax Expenses | 288.89% | 92.56% | -39.36% | 108.63% | 15.71% |
| Earnings from Continuing Operations | 1.08% | -367.64% | -340.31% | -50.95% | -203.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.08% | -367.64% | -340.31% | -50.95% | -203.18% |
| EBIT | 77.61% | 50.32% | 75.67% | 37.27% | -39.09% |
| EBITDA | 156.11% | 144.85% | 216.26% | 137.33% | -90.89% |
| EPS Basic | 6.86% | -341.64% | -286.87% | -29.68% | -158.23% |
| Normalized Basic EPS | 65.71% | 39.31% | 56.57% | 22.78% | -80.51% |
| EPS Diluted | 6.86% | -341.64% | -286.87% | -29.68% | -158.23% |
| Normalized Diluted EPS | 65.71% | 39.31% | 56.57% | 22.78% | -80.51% |
| Average Basic Shares Outstanding | 6.23% | 5.89% | 13.82% | 16.44% | 17.40% |
| Average Diluted Shares Outstanding | 6.23% | 5.89% | 13.82% | 16.44% | 17.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |